CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Infliximab and adalimumab in TNF-αnaïve Crohn's disease patients: Austrian multicentre cohort study
DOI 10.1055/s-0034-1375981
Bibliografische Angaben
Nachweis in CareLit
Autor:innenP Papay, S Kainz, W Petritsch, T Haas, T Feichtenschlager, G Novacek, A Eser, H Vogelsang, W Reinisch
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe05/2014
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background/Aim: Tumor necrosis factor-α inhibitors (TNFi), infliximab (IFX) & adalimumab (ADA) revolutionized the treatment of Crohn's disease (CD). However, despite their broad clinical use, studies comparing their efficacy in TNF-α naïve CD patients are missing. Patients/Methods: Consecutive TNF-α naïve patients with luminal CD from four tertiary centers were retrospectively analyzed for short- and long-term effic…
Zitieren
Zitierempfehlung
P Papay, S Kainz, W Petritsch, T Haas, T Feichtenschlager, G Novacek, A Eser, H Vogelsang, W Reinisch (2014) Infliximab and adalimumab in TNF-αnaïve Crohn's disease patients: Austrian multicentre cohort study. Zeitschrift für Gastroenterologie (05). https://doi.org/10.1055/s-0034-1375981
Mit CareLit weiterarbeiten